Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UMPS | P11172 | 1/20 | 0.66 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.62 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.62 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.59 |
| ▸ | NT5E | P21589 | 2/20 | 0.58 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18574261 | 0.90 | UMPS (0.53) | UMPSP2RY2P2RY6P2RY4NT5E | |
| SCHEMBL14946368 | 0.90 | UMPS (0.53) | UMPSP2RY2P2RY6P2RY4NT5E | |
| SCHEMBL14929324 | 0.90 | UMPS (0.53) | UMPSP2RY2P2RY6P2RY4NT5E | |
| SCHEMBL18574264 | 0.89 | NT5E (0.67) | P2RY2P2RY6P2RY4NT5E | |
| SCHEMBL14929505 | 0.89 | NT5E (0.67) | P2RY2P2RY6P2RY4NT5E | |
| SCHEMBL29185234 | 0.89 | NT5E (0.67) | P2RY2P2RY6P2RY4NT5E | |
| SCHEMBL14946397 | 0.89 | NT5E (0.67) | P2RY2P2RY6P2RY4NT5E | |
| SCHEMBL21742443 | 0.89 | P2RY6 (0.69) | P2RY6NT5EP2RY14 | |
| SCHEMBL31685495 | 0.89 | UMPS (0.77) | UMPSP2RY2P2RY6P2RY4NT5E | |
| SCHEMBL28360509 | 0.86 | UMPS (0.66) | UMPSP2RY2P2RY6P2RY4P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | UMPS 770/4885P2RY2 3116/4885P2RY6 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.